Results 231 to 240 of about 651,453 (295)

The difficult discussion on the deactivation of implantable cardioverter devices at the end of life: a systematic review

ESC Heart Failure, Volume 12, Issue 2, Page 733-760, April 2025.
Abstract Implantable cardioverter defibrillators (ICDs) reliably prevent death due to life‐threatening arrhythmias; this may become less relevant in people with more severe heart failure who are reaching the end of life (EOL). This review aimed to explore the ICD deactivation process and identify ethical issues, especially around the initiation of ...
Siobhan C. Murray, Claire McNamara, Anna V. Chatzi   +2 more
wiley   +1 more source

Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues

ESC Heart Failure, Volume 12, Issue 2, Page 1059-1080, April 2025.
Abstract Systemic aging influences various physiological processes and contributes to structural and functional decline in cardiac tissue. These alterations include an increased incidence of left ventricular hypertrophy, a decline in left ventricular diastolic function, left atrial dilation, atrial fibrillation, myocardial fibrosis and cardiac ...
Zhuyubing Fang, Umar Raza, Jia Song, Junyan Lu, Shun Yao, Xiaohong Liu, Wei Zhang, Shujuan Li   +7 more
wiley   +1 more source

Effects of metformin treatment on the risk of acute myocardial infarction. [PDF]

Sci Rep
Chang CC, Chou YC, Yang T, Chang JY, Sun CA.   +4 more
europepmc   +1 more source

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source

Acute myocardial infarction in a young patient with Chikungunya: a case report. [PDF]

Rev Inst Med Trop Sao Paulo
Costa JG, Sousa PMB, Orsi MM, Campos MAG, Ataides RJC, Lages JS, Silva GEB.   +6 more
europepmc   +1 more source

A CASE: NANDA DIAGNOSES AND NIC INTERVENTIONS WITH NURSING CARE IN ACUTE MYOCARDIAL INFARCTION

, 2016
Yeter Kurt, Çiğdem Gamze ÖZKAN, Birsel Canan DEMİRBAĞ   +2 more
openalex   +1 more source

Clinical Significance of Acute-Phase Endothelin-1 in Acute Myocardial Infarction Patients Treated With Direct Coronary Angioplasty

, 2005
Toshiro Katayama, Katsusuke Yano, Hiroshi Nakashima, Chisa Takagi, Yukiharu Honda, Shin Suzuki, Yoshihiro Iwasaki   +6 more
openalex   +2 more sources

Meta‐analysis of sotagliflozin, a dual sodium‐glucose‐cotransporter 1/2 inhibitor, for heart failure in type 2 diabetes

ESC Heart Failure, Volume 12, Issue 2, Page 968-979, April 2025.
Abstract Sodium‐glucose co‐transporters (SGLTs) mediate sodium and glucose transport across cell membranes. SGLT2 inhibitors have a recognized place within heart failure (HF) guidelines. We evaluated the effect of sotagliflozin on HF and cardiovascular outcomes in participants with type 2 diabetes. Scopus, Medline, Embase and Central were searched from
Maria Anna Bantounou, Panagiotis Sardellis, Josip Plascevic, Ribeya Awaes‐Mahmood, Justyna Kaczmarek, Daniel Black Boada, Rosa Thuemmler, Sam Philip   +7 more
wiley   +1 more source

Exploring sex differences in mortality among acute myocardial infarction. [PDF]

Open Heart
Cangiano L, Bonomi A, Cosentino N, Leoni O, Trombara F, Myasoedova VA, Poggio P, Trabattoni D, Agostoni P, Marenzi G.   +9 more
europepmc   +1 more source

Lesion-Specific Variations in ST-Segment Elevation and Clinical Outcomes in Acute Inferior Myocardial Infarction: Insights from Bangladesh

AKS Zahid Mahmud Khan, AKM Monwarul Islam, Abdul Momen, Atikur Rahman, Rasha E. Hassan   +4 more
openalex   +1 more source